CCJ vs UEC: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CCJ and UEC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CCJ and UEC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Cameco (CCJ) is one of the world's largest publicly traded uranium producers and a major supplier of nuclear fuel. Based in Saskatchewan, Canada, it mines uranium from some of the highest-grade deposits in the world, including the Cigar Lake and McArthur River operations, and sells uranium concentrate (U3O8) to utilities that run nuclear power plants. Beyond mining, Cameco participates across the nuclear fuel cycle through refining, conversion, and fuel-fabrication activities, and it holds a significant interest in Westinghouse, a leading provider of nuclear reactor technology and services, acquired alongside Brookfield. Cameco's revenue is tied to long-term contracts with utilities and to uranium spot and contract prices, which are driven by global nuclear power demand, supply discipline, and the broader case for clean, baseload electricity. It trades on the New York Stock Exchange and the Toronto Stock Exchange.

Full CCJ guide

Uranium Energy Corp (UEC) is a US-based uranium mining and exploration company focused on low-cost in-situ recovery (ISR) production in the United States, primarily in Texas and Wyoming, along with conventional projects in Canada (Athabasca Basin) and Paraguay. The company positions itself as a leading domestic supplier of uranium for nuclear power, holding a physical uranium inventory and a portfolio of licensed and permitted projects it can bring online as prices justify. UEC does not pay a dividend and reinvests in expanding production capacity, acquisitions, and a physical uranium stockpile. Its thesis is leveraged to the price of uranium (U3O8) and to the broader revival of nuclear power demand. Headquartered in Corpus Christi, Texas, UEC is a speculative, commodity-price-sensitive equity rather than a steady-cash producer.

Full UEC guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CCJ drivers: Nuclear demand and the clean-energy case; Uranium supply discipline and pricing.
• UEC drivers: Leverage to the uranium price; Domestic supply and nuclear revival.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events. For UEC, uEC is speculative and pre-scale.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CCJ if you believe its drivers more; UEC if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CCJ and UEC guides.

CCJ. Cameco trades on a very high multiple of current earnings (about 139 times trailing and 45 times forward as of October 16, 2026) because the market is valuing its long-term uranium contract book and Westinghouse stake rather than one year of lumpy profits. Analysts' consensus calls for EPS to rise from about C$1.45 in 2026 to about C$2.60 in 2027; the mean analyst target of about $128 sits well above the $82.04 close. The balance sheet is light, with about C$1.1 billion of cash against C$1.2 billion of debt.

UEC. UEC is valued mostly on its uranium resource base, physical inventory, cash and leverage to the uranium price rather than on earnings, since it lost money in fiscal 2026 and analysts expect losses again in fiscal 2027 and 2028. At roughly 106 times trailing sales and about 2.9 times book, the price still embeds a large production ramp, even after a 50% one-year fall. The 11 covering analysts have a mean target near $16, while RBC started coverage in October 2026 at Sector Perform, Speculative Risk, with a $10 target.

Headline figures (approximate, October 2026): CCJ shows revenue (ttm) ~C$3.5 billion, revenue growth (q2 2026, yoy) ~-7%, net income (ttm) ~C$355 million, operating margin (ttm) ~9%; UEC shows share price / market cap (oct 16, 2026) ~$7.99 / ~$4.0 billion, stock performance YTD ~-39%, 1-year ~-50%, revenue (fiscal year to july 31, 2026) ~$37 million, down from ~$67 million, net income (fiscal 2026) ~-$137 million (EPS ~-$0.28).

CCJ and UEC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CCJ and UEC exposure against your real portfolio. It is not an investment adviser.